Reactome | SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial

Schema > LiteratureReference > Entries

SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial Show undefined attributes

author	[Person:9734379] Zheng, F [Person:9734385] Zhou, Y [Person:9734413] Zhou, Z [Person:6799037] Ye, F [Person:9683896] Huang, B [Person:9734381] Huang, Y [Person:3009208] Ma, J [Person:9734409] Zuo, Q [Person:9734402] Tan, X [Person:3769003] Xie, J [Person:9683884] Niu, P [Person:9734393] Wang, W [Person:9734415] Xu, Y [Person:9734428] Peng, F [Person:9734389] Zhou, N [Person:9734425] Cai, C [Person:3640755] Tang, W [Person:9734380] Xiao, X [Person:5318560] Li, Y [Person:9654800] Zhou, Z [Person:9734390] Jiang, Y [Person:9734411] Xie, Y [Person:9683897] Tan, W [Person:9734426] Gong, G
created	[InstanceEdit:9734386] Stephan, Ralf, 2021-06-17
dbId	9734399
displayName	SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial
journal	Int J Infect Dis
pages	84-91
pubMedIdentifier	32758689
schemaClass	LiteratureReference
title	SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial
url	http://www.ncbi.nlm.nih.gov/pubmed/32758689
volume	99
year	2020

Referrals

(literatureReference)

[Reaction:R-HSA-9696179] IFNAR2:JAK1:STAT2 binds type 1 interferon analogs

(author)

© 2026 Reactome

Cite Us!